Aberer, W; Kuna, P; Bjermer, L; Pfaar, O; Zielen, S; Berger, U; Lee, D; Seybold, M; Ernst, A; Clausen, A; Lis, K; Wittmann, A; Gunawardena, K; Skinner, MA; Higenbottam, T.
Design of a pivotal phase III allergen immunotherapy study to assess the efficacy and safety of subcutaneously administered tyrosine adsorbed modified birch allergen plus MPL
ALLERGY. 2018; 73: 629-630.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science